Inspira Technologies OXY BHN Ltd. has announced a significant breakthrough in its expansion efforts, successfully achieving all key objectives in its discussions with a government health authority outside the United States. This achievement establishes a clear pathway for the nationwide adoption of Inspira's ART100 system and sets the groundwork for a future global scale-up. The ART100, recognized as a clinically validated and field-proven system, will be integrated into the country's national emergency infrastructure. This strategic move not only validates Inspira's plans but also accelerates the execution of an existing $22.5 million purchase order. The development is seen as a pivotal moment for Inspira Technologies, enabling the company to build a government-aligned, global commercial platform.